Spots Global Cancer Trial Database for vad
Every month we try and update this database with for vad cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma | NCT00580372 | Multiple Myelom... | VAD High-Dose cyclo... Hemopoietic ste... EDAP Autologous Hemo... Autologous Hemo... Maintenance | 18 Years - | University of Arkansas | |
UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma | NCT00580372 | Multiple Myelom... | VAD High-Dose cyclo... Hemopoietic ste... EDAP Autologous Hemo... Autologous Hemo... Maintenance | 18 Years - | University of Arkansas | |
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy | NCT00083551 | Multiple Myelom... | Thalidomide Ara-C BCNU Cisplatin Cytoxan Dexamethasone Doxorubicin Etoposide Filgrastim Recombinant GM-... Interferon-alph... Melphalan Vincristine | 18 Years - 75 Years | University of Arkansas |